- You are here: Home
- Applications
- Neurological Disorder
- Alzheimer's Disease Modeling and Assays
- In Vivo Model Service
- Transgenic Animal Models
- Tau Transgenic Models
Applications
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Tau Transgenic Models
Neurofbrillary tangles (NFTs) are neuronal inclusions of the microtubule-associated protein (MAP) tau. Its aggregated and hyperphosphorylated form are considered to be one of the most important histopathological hallmarks of Alzheimer’s disease. Transgenic mouse model that express the mutated human tau has been generated to mimic the characteristics of neurofibrillary tangles in Alzheimer's disease. Creative Bioarray specializes in providing customized pharmacodynamic research services to help customers assess the efficacy of drug candidates and study the associated pathological mechanisms through Tau transgenic models.
Tau transgenic models include but not limited to:
- Tau (P301L) [JNPL3] mouse
Our Capabilities
- We offer Tau transgenic models to screen drug candidates for treatment of Alzheimer's disease.
- We provide comprehensive behavioral and cognitive testing on AD model and the drug screening.
- We evaluate various biomarkers through WB, IHC, ELISA, sequencing, etc.
Assays available
- Learning and memory deficits tests
- Synaptic impairment
- Phosphorylated tau
- Neurofilament Light Chain levels
- Neuronal loss
- Brain slice staining and synaptic electrophysiology
With extensive experience in the field of AD, we are confident to help you to overcome any upcoming challenges. Our experts are fully capable of customizing our protocols and assays to meet your specific needs. With our help, we wish to facilitate your research with high efficiency.
Study examples
Figure. 1. Characterization of NFT from P301L (JNPL3) mice. NFT stained with Congo red under light microscopy (a), with polarization (b), and under confocal microscopy (c). Thioflavin-S (d) also stained NFT. NFT were positive with Gallyas (e), Bielschowsky (f) and Bodian (g) silver stains. Ubiquitin immunostaining was identified in most NFT (h). Tau hyperphosphorylation was evident from staining with numerous tau antibodies that recognize specific phosphoepitopes including AT8 (i and inset), AT180 (j) and CP13 (k). All sections are from spinal cord except (k), which is from cerebellar dentate nucleus.
Figure. 2. Electron microscopy of NFT in P301L (JNPL3) mice. a, A neuron with a NFT shows deep nuclear infolding (N) and filamentous cytoplasmic aggregates (boxed area; bar, 1 µm). b, Magnification of boxed area in (a) shows filaments in longitudinal and cross sections. L, lipofuscin granule; N, nucleus; R, polyribosomes. Bar, 0.2 µm. c, Immunogold labelling (CP13) of neuronal filaments (bar, 0.1 µM). d, Immunolabelling of filaments (CP13) with arrows indicating heavy peroxidase reaction product association (bar, 0.2 µm).
Quotation and ordering
If you have any special needs or questions regarding our services, please feel free to contact us. We look forward to cooperating with you in the future.
Reference
Lewis J et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet. 2000 Aug;25(4):402-5.
Explore Other Options
For research use only. Not for any other purpose.